Search details
1.
Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.
Cancer
; 2024 Jun 02.
Article
in English
| MEDLINE | ID: mdl-38824658
2.
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
Mol Cancer
; 22(1): 178, 2023 11 06.
Article
in English
| MEDLINE | ID: mdl-37932736
3.
A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer.
Gynecol Oncol
; 171: 106-113, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36868112
4.
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.
Cancer Immunol Immunother
; 70(2): 519-531, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-32852603
5.
Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape.
Gynecol Oncol
; 160(1): 279-284, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33162175
6.
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours.
Br J Cancer
; 122(4): 564-568, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31844183
7.
Tepotinib Efficacy in a Patient with Non-Small Cell Lung Cancer with Brain Metastasis Harboring an HLA-DRB1-MET Gene Fusion.
Oncologist
; 25(11): 916-920, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32716573
8.
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT).
Gynecol Oncol
; 159(1): 129-135, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32723678
9.
Corrigendum to "A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer".
Gynecol Oncol
; 175: 194, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37271667
10.
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer.
BJU Int
; 121(2): 203-208, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28370882
11.
Updates in the Use of Targeted Therapies for Gynecologic Cancers.
Am Soc Clin Oncol Educ Book
; 44(3): e438582, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38788185
12.
[Current post-surgical treatment strategies in first-line ovarian cancer]. / Stratégies thérapeutiques post-chirurgicales actuelles dans les cancers de l'ovaire en première ligne de traitement.
Bull Cancer
; 111(3): 267-276, 2024 Mar.
Article
in French
| MEDLINE | ID: mdl-36863923
13.
Spatial profiling of ovarian carcinoma and tumor microenvironment evolution under neoadjuvant chemotherapy.
Clin Cancer Res
; 2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38669064
14.
[Immunotherapy in oncogynaecology]. / Immunothérapies validées en oncogynécologie.
Bull Cancer
; 110(4): 395-401, 2023 Apr.
Article
in French
| MEDLINE | ID: mdl-36759214
15.
Targeting the immune microenvironment for ovarian cancer therapy.
Front Immunol
; 14: 1328651, 2023.
Article
in English
| MEDLINE | ID: mdl-38164130
16.
Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment.
Clin Cancer Res
; 29(22): 4679-4684, 2023 11 14.
Article
in English
| MEDLINE | ID: mdl-37699075
17.
Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer.
Clin Cancer Res
; 29(16): 3124-3129, 2023 08 15.
Article
in English
| MEDLINE | ID: mdl-37067532
18.
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer.
Eur J Cancer
; 195: 113368, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37897866
19.
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Lung Cancer
; 178: 116-122, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36812760
20.
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
JCO Precis Oncol
; 7: e2200583, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36862966